Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Jones

Showing results (661-670 of 818) with videos related to

Pageof 82
Sort By:
Diagnostic Microbiology and Infectious Disease|November 1, 1989
Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strainsR N Jones, M A Pfaller, P C Fuchs, et al.
Journal of Clinical Microbiology|November 1, 1988
Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion testA L Barry, P B Fernandes, J H Jorgensen, et al.
Journal of Clinical Microbiology|March 26, 2010
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida speciesM A Pfaller, M Castanheira, D J Diekema, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1996
Comparative activity of twelve beta-lactam drugs tested against penicillin-resistant Streptococcus pneumoniae from five medical centers: effects of serum protein and capsular material on potency and spectrum as measured by reference testsD M Johnson, G V Doern, T A Haugen, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1981
Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility testsC Thornsberry, A L Barry, R N Jones, et al.
Journal of Clinical Microbiology|January 9, 2003
In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from bloodM A Pfaller, D J Diekema, S A Messer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1993
Outbreak of Pseudomonas aeruginosa infections in a surgical intensive care unit: probable transmission via hands of a health care workerA F Widmer, R P Wenzel, A Trilla, et al.
European Journal of Clinical Microbiology|February 1, 1986
In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility testsA L Barry, R N Jones, C Thornsberry, et al.
British Journal of Industrial Medicine|February 1, 1989
Progression of asbestos effects: a prospective longitudinal study of chest radiographs and lung functionR N Jones, J E Diem, J M Hughes, et al.
Journal of Clinical Microbiology|June 1, 2018
Delafloxacin <i>In Vitro</i> Broth Microdilution and Disk Diffusion Antimicrobial Susceptibility Testing Guidelines: Susceptibility Breakpoint Criteria and Quality Control Ranges for an Expanded-Spectrum Anionic FluoroquinoloneM A Pfaller, R K Flamm, S P McCurdy, et al.
Pageof 82

Showing results (661-670 of 818) with videos related to

Sort By:
Pageof 82
Diagnostic Microbiology and Infectious Disease|November 1, 1989
Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strainsR N Jones, M A Pfaller, P C Fuchs, et al.
Journal of Clinical Microbiology|November 1, 1988
Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion testA L Barry, P B Fernandes, J H Jorgensen, et al.
Journal of Clinical Microbiology|March 26, 2010
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida speciesM A Pfaller, M Castanheira, D J Diekema, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1996
Comparative activity of twelve beta-lactam drugs tested against penicillin-resistant Streptococcus pneumoniae from five medical centers: effects of serum protein and capsular material on potency and spectrum as measured by reference testsD M Johnson, G V Doern, T A Haugen, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1981
Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility testsC Thornsberry, A L Barry, R N Jones, et al.
Journal of Clinical Microbiology|January 9, 2003
In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from bloodM A Pfaller, D J Diekema, S A Messer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1993
Outbreak of Pseudomonas aeruginosa infections in a surgical intensive care unit: probable transmission via hands of a health care workerA F Widmer, R P Wenzel, A Trilla, et al.
European Journal of Clinical Microbiology|February 1, 1986
In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility testsA L Barry, R N Jones, C Thornsberry, et al.
British Journal of Industrial Medicine|February 1, 1989
Progression of asbestos effects: a prospective longitudinal study of chest radiographs and lung functionR N Jones, J E Diem, J M Hughes, et al.
Journal of Clinical Microbiology|June 1, 2018
Delafloxacin <i>In Vitro</i> Broth Microdilution and Disk Diffusion Antimicrobial Susceptibility Testing Guidelines: Susceptibility Breakpoint Criteria and Quality Control Ranges for an Expanded-Spectrum Anionic FluoroquinoloneM A Pfaller, R K Flamm, S P McCurdy, et al.
Pageof 82